Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical Trials Insight: 700032156

Trial Profile

Clinical Trials Insight: 700032156

Phase of Trial: Phase III

Latest Information Update: 29 Apr 2009

At a glance

  • Drugs Cintredekin besudotox (Primary)
  • Indications Glioblastoma
  • Focus Registrational; Therapeutic Use
  • Sponsors NeoPharm Inc
  • Most Recent Events

    • 29 Apr 2009 Status changed from planning to discontinued. Regulary approval has not been granted by the Directorate General of Health Services - Office of Drugs Controller General (India). DCGI requested concurrent enrolment of patients in the trial in the USA.
    • 13 May 2008 IND submission expected olate 2008.
    • 03 Apr 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top